Product Information
KETOCONAZOLE 2% FOAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $3.2761 per GM under NDC 45802053233. Its NADAC has been published 170 times since Nov 28, 2013.
FDA first approved this application on Aug 25, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the ketoconazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 g/100g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802053233
Classification
Generic
Dosage Form
AEROSOL, FOAM
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
KETOCONAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA091550FDA Approved
8/25/2011
TE Code
AB
On Market Since
8/30/2011
Pharmacological Classes
Price Statistics
The NADAC for KETOCONAZOLE 2% FOAM has been published 170 times since Nov 28, 2013, and over the history we have for it it has risen 13.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.2761 per GM |
|---|---|
| All-time high | $3.8345 (Nov 13, 2024) |
| All-time low | $2.3325 (Jan 21, 2026) |
| 52-week high | $3.2761 |
| 52-week low | $2.3325 |
| Median price | $2.8842 |
| Average price | $3.0098 |
| Largest weekly change | +26.8% (Jul 17, 2024) |
| Weeks tracked | 170 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of KETOCONAZOLE 2% FOAM?
The current National Average Drug Acquisition Cost (NADAC) for KETOCONAZOLE 2% FOAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $3.2761 per GM (NDC 45802053233), effective Aug 19, 2026.
How has the price of KETOCONAZOLE 2% FOAM changed over time?
Over the history we have for it, the NADAC for KETOCONAZOLE 2% FOAM has risen 13.6%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for KETOCONAZOLE 2% FOAM?
Since Nov 28, 2013, the NADAC for KETOCONAZOLE 2% FOAM has ranged from a low of $2.3325 (Jan 21, 2026) to a high of $3.8345 (Nov 13, 2024), with a median of $2.8842 per GM.
Are there cheaper alternatives to KETOCONAZOLE 2% FOAM?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as KETOCONAZOLE 2% FOAM in a comparable dosage form, but none are currently priced below it.
Who manufactures KETOCONAZOLE 2% FOAM?
KETOCONAZOLE 2% FOAM (NDC 45802053233) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.